{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:46:34Z","timestamp":1793533594457,"version":"4.5.0"},"reference-count":39,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"abstract":"<jats:p>This policy statement revises a previous statement on screening of preterm infants for retinopathy of prematurity (ROP) that was published in 2013. ROP is a pathologic process that occurs in immature retinal tissue and can progress to a tractional retinal detachment, which may then result in visual loss or blindness. For more than 3 decades, treatment of severe ROP that markedly decreases the incidence of this poor visual outcome has been available. However, severe, treatment-requiring ROP must be diagnosed in a timely fashion to be treated effectively. The sequential nature of ROP requires that infants who are at-risk and preterm be examined at proper times and intervals to detect the changes of ROP before they become destructive. This statement presents the attributes of an effective program to detect and treat ROP, including the timing of initial and follow-up examinations.<\/jats:p>","DOI":"10.1542\/peds.2018-3061","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T08:29:24Z","timestamp":1543220964000},"source":"Crossref","is-referenced-by-count":626,"title":["Screening Examination of Premature Infants for Retinopathy of Prematurity"],"prefix":"10.1542","volume":"142","author":[{"given":"Walter M.","family":"Fierson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"AMERICAN ACADEMY OF PEDIATRICS Section on Ophthalmology","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"AMERICAN ACADEMY OF OPHTHALMOLOGY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"AMERICAN ASSOCIATION FOR PEDIATRIC OPHTHALMOLOGY AND STRABISMUS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"AMERICAN ASSOCIATION OF CERTIFIED ORTHOPTISTS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Phelps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira L.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Karr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey E.","family":"Bradford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanwal","family":"Nischal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Roarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donny Won","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon S.","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"George S.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2018,12,1]]},"reference":[{"issue":"4","key":"2021120913464391400_B1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archopht.1988.01060130517027","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results.","volume":"106","author":"Cryotherapy for Retinopathy of Prematurity Cooperative Group","year":"1988","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"2021120913464391400_B2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archopht.123.3.311","article-title":"15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity.","volume":"123","author":"Palmer","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"2021120913464391400_B3","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0161-6420(91)32247-4","article-title":"Laser photocoagulation for stage 3+ retinopathy of prematurity.","volume":"98","author":"McNamara","year":"1991","journal-title":"Ophthalmology"},{"issue":"2","key":"2021120913464391400_B4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0161-6420(93)31664-7","article-title":"Diode laser photocoagulation for threshold retinopathy of prematurity. A randomized study.","volume":"100","author":"Hunter","year":"1993","journal-title":"Ophthalmology"},{"issue":"2","key":"2021120913464391400_B5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archopht.1994.01090140028007","article-title":"Laser therapy for retinopathy of prematurity.","volume":"112","author":"Laser ROP Study Group","year":"1994","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"2021120913464391400_B6","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1001\/archopht.1991.01080100022007","article-title":"Laser photocoagulation for threshold retinopathy of prematurity.","volume":"109","author":"Iverson","year":"1991","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"2021120913464391400_B7","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.","volume":"121","author":"Early Treatment for Retinopathy of Prematurity Cooperative Group","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"2021120913464391400_B8","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2004-1180","article-title":"Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs.","volume":"115","author":"Gilbert","year":"2005","journal-title":"Pediatrics"},{"issue":"2","key":"2021120913464391400_B9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control.","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum Dev"},{"issue":"7","key":"2021120913464391400_B10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The international classification of retinopathy of prematurity revisited.","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"2021120913464391400_B11","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0161-6420(91)32074-8","article-title":"Incidence and early course of retinopathy of prematurity.","volume":"98","author":"Palmer","year":"1991","journal-title":"Ophthalmology"},{"issue":"5","key":"2021120913464391400_B12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3928\/0191-3913-19990901-06","article-title":"The design of the multicenter study of light reduction in retinopathy of prematurity (LIGHT-ROP).","volume":"36","author":"LIGHT-ROP Cooperative Group","year":"1999","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"5","key":"2021120913464391400_B13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1001\/archopht.116.5.608","article-title":"Timing of initial screening examinations for retinopathy of prematurity.","volume":"116","author":"Hutchinson","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"22","key":"2021120913464391400_B14","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJM199805283382202","article-title":"Lack of efficacy of light reduction in preventing retinopathy of prematurity.","volume":"338","author":"Reynolds","year":"1998","journal-title":"N Engl J Med"},{"issue":"11","key":"2021120913464391400_B15","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1001\/archopht.120.11.1470","article-title":"Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies.","volume":"120","author":"Reynolds","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"2021120913464391400_B16","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/archopht.124.12.1711","article-title":"Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity.","volume":"124","author":"L\u00f6fqvist","year":"2006","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"2021120913464391400_B17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jaapos.2016.01.017","article-title":"Colorado retinopathy of prematurity model: a multi-institutional validation study.","volume":"20","author":"Cao","year":"2016","journal-title":"J AAPOS"},{"issue":"12","key":"2021120913464391400_B18","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1001\/archophthalmol.2012.2524","article-title":"The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model.","volume":"130","author":"Binenbaum","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"2021120913464391400_B19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3928\/23258160-20160229-12","article-title":"Very late reactivation of retinopathy of prematurity after monotherapy with intravitreal bevacizumab.","volume":"47","author":"Snyder","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"3","key":"2021120913464391400_B20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/ICB.0b013e318285238e","article-title":"Delayed recurrent neovascularization and persistent avascular retina following intravitreal bevacizumab for retinopathy of prematurity.","volume":"7","author":"Mehta","year":"2013","journal-title":"Retin Cases Brief Rep"},{"issue":"3","key":"2021120913464391400_B21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3928\/23258160-20170301-10","article-title":"Reactivation of retinopathy of prematurity three years after treatment with bevacizumab.","volume":"48","author":"Hajrasouliha","year":"2017","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"5","key":"2021120913464391400_B22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archopht.118.5.645","article-title":"Involution of retinopathy of prematurity.","volume":"118","author":"Repka","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"2021120913464391400_B23","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-0978","article-title":"Telemedicine for evaluation of retinopathy of prematurity.","volume":"135","author":"Fierson","year":"2015","journal-title":"Pediatrics"},{"issue":"9","key":"2021120913464391400_B24","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00417-009-1077-7","article-title":"Wide-field digital imaging based telemedicine for screening for acute retinopathy of prematurity (ROP). Six-year results of a multicentre field study.","volume":"247","author":"Lorenz","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"2021120913464391400_B25","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2014.1604","article-title":"Validity of a telemedicine system for the evaluation of acute-phase retinopathy of prematurity.","volume":"132","author":"Quinn","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"2021120913464391400_B26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3928\/15428877-20100929-08","article-title":"Stanford University network for diagnosis of retinopathy of prematurity (SUNDROP): 36-month experience with telemedicine screening.","volume":"42","author":"Silva","year":"2011","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"11","key":"2021120913464391400_B27","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archopht.125.11.1531","article-title":"Telemedical retinopathy of prematurity diagnosis: accuracy, reliability, and image quality.","volume":"125","author":"Chiang","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"2021120913464391400_B28","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.ophtha.2007.09.006","article-title":"Telemedical diagnosis of retinopathy of prematurity intraphysician agreement between ophthalmoscopic examination and image-based interpretation.","volume":"115","author":"Scott","year":"2008","journal-title":"Ophthalmology"},{"issue":"6","key":"2021120913464391400_B29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archophthalmol.2010.72","article-title":"Final visual acuity results in the early treatment for retinopathy of prematurity study.","volume":"128","author":"Good","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"2021120913464391400_B30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"2021120913464391400_B31","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00417-008-0786-7","article-title":"Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity.","volume":"246","author":"Honda","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"2021120913464391400_B32","doi-asserted-by":"crossref","first-page":"e20153218","DOI":"10.1542\/peds.2015-3218","article-title":"Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity.","volume":"137","author":"Morin","year":"2016","journal-title":"Pediatrics"},{"issue":"4","key":"2021120913464391400_B33","doi-asserted-by":"crossref","first-page":"e20160057","DOI":"10.1542\/peds.2016-0057","article-title":"Concerns for development after bevacizumab treatment of ROP","volume":"137","author":"Quinn","year":"2016","journal-title":"Pediatrics"},{"issue":"6","key":"2021120913464391400_B34","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/02713683.2014.941070","article-title":"Preliminary anatomical and neurodevelopmental outcomes of intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity.","volume":"40","author":"Araz-Ersan","year":"2015","journal-title":"Curr Eye Res"},{"issue":"11","key":"2021120913464391400_B35","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","article-title":"Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial.","volume":"132","author":"Geloneck","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"2021120913464391400_B36","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archophthalmol.2012.592","article-title":"Reactivation of retinopathy of prematurity after bevacizumab injection.","volume":"130","author":"Hu","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"2021120913464391400_B37","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.ophtha.2016.04.028","article-title":"Clinical management of recurrent retinopathy of prematurity after intravitreal bevacizumab monotherapy.","volume":"123","author":"Mintz-Hittner","year":"2016","journal-title":"Ophthalmology"},{"issue":"5","key":"2021120913464391400_B38","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/eye.2009.156","article-title":"Paradoxical vascular-fibrotic reaction after intravitreal bevacizumab for retinopathy of prematurity [published correction appears in Eye (Lond). 2010;24(1):202].","volume":"24","author":"Zepeda-Romero","year":"2010","journal-title":"Eye (Lond)"},{"issue":"1","key":"2021120913464391400_B39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1542\/peds.2012-2996","article-title":"Screening examination of premature infants for retinopathy of prematurity.","volume":"131","author":"Fierson","year":"2013","journal-title":"Pediatrics"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2018-3061\/1075485\/peds_20183061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2018-3061\/1075485\/peds_20183061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T22:51:44Z","timestamp":1639090304000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/142\/6\/e20183061\/37478\/Screening-Examination-of-Premature-Infants-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,12,1]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2018-3061","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,1]]},"article-number":"e20183061"}}